2-(ethoxymethylene)-3-(2-methoxypyrimidin-5-yl)propionic acid ethyl ester | 224776-37-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-(ethoxymethylene)-3-(2-methoxypyrimidin-5-yl)propionic acid ethyl ester
• CAS: 224776-37-8
• 化学式: C₁₂H₁₆N₂O₄
• 分子量: 252.27
• InChiKey: BDRRZSJKUDRFBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.12
• 重原子数：
  18.0
• 可旋转键数：
  6.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  70.54
• 氢给体数：
  0.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  2-(ethoxymethylene)-3-(2-methoxypyrimidin-5-yl)propionic acid ethyl ester 在 sodium hydroxide 、 草酰氯 作用下， 以 1,2-二氯乙烷 为溶剂， 生成 (Z)-3-Methoxy-2-(2-methoxy-pyrimidin-5-ylmethyl)-acryloyl chloride
  参考文献：
  名称：

  The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2

  摘要：

  Modification of the pyrimidone 5-substituent in a series of 1-((amidolinked)-alkyl)-pyrimidones, lipophilic inhibitors of lipoprotein-associated phospholipase A(2), has given inhibitors of nanomolar potency and improved physicochemical properties. Compound 23 was identified as a potent, highly water soluble, CNS penetrant inhibitor suitable for intravenous administration. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00038-5
• 作为产物：
  描述：

  ethyl 3-(2-methoxypyrimidin-5-yl)propionate 在 sodium hydride 、 potassium carbonate 作用下， 以 乙二醇二甲醚 、 N,N-二甲基甲酰胺 为溶剂， 生成 2-(ethoxymethylene)-3-(2-methoxypyrimidin-5-yl)propionic acid ethyl ester
  参考文献：
  名称：

  The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2

  摘要：

  Modification of the pyrimidone 5-substituent in a series of 1-((amidolinked)-alkyl)-pyrimidones, lipophilic inhibitors of lipoprotein-associated phospholipase A(2), has given inhibitors of nanomolar potency and improved physicochemical properties. Compound 23 was identified as a potent, highly water soluble, CNS penetrant inhibitor suitable for intravenous administration. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00038-5

文献信息

• Pyrimidinone compounds
  申请人：SmithKline Beecham p.l.c.

  公开号：US20040167142A1

  公开（公告）日：2004-08-26

  Pyrimidinone compounds of formula (I) are inhibitors of the enzyme Lp-PLA 2 and of use in therapy, in particular for treating atherosclerosis. 1

  式（I）的嘧啶酮化合物是Lp-PLA2酶的抑制剂，可用于治疗，特别是用于治疗动脉粥样硬化。